An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing - ScienceDirect
Omicron COVID variant: No cases in Pa., Del., N.J. yet - WHYY
Genome Characterization and Potential Risk Assessment of the Novel SARS-CoV-2 Variant Omicron (B.1.1.529) – ScienceOpen
Omicron: How do I know if I have it? - BBC News
Reagents for coronavirus omicron variant research
An Imported Case of BA.2 Lineage of Omicron Variant COVID-19 — Guangdong Province, China, December 28, 2021
Omicron (BA.2) variant | Expression vectors | InvivoGen
Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant - ScienceDirect
Omicron variant puts US coronavirus sequencing to the test | CNN
Omicron: What we know about Covid strain prompting fresh global restrictions | Financial Times
The Omicron Variant Won't Slip Past This UVA Lab | UVA Today
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa | Nature
Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa - Wang - 2022 - Journal of Medical Virology - Wiley Online Library
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021 | MMWR
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? | Journal of Virology
Rapid Establishment of Omicron Variant in Rio Grande do Sul State, Brazil - SARS-CoV-2 coronavirus - Virological
The Hunt for Coronavirus Variants: How the New One Was Found and What We Know So Far | Today's Clinical Lab
Vaccines | Free Full-Text | Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
CDC's Role in Tracking Variants | CDC
Sanger Sequencing for SARS-CoV-2 Omicron Variant Surveillance
Omicron (B.1.1.529) variant | Pseudotyping plasmid | InvivoGen
Omicron Variant: “A Little Too Much Hype, Saying This Is the Next Scary Thing” | The Brink | Boston University
Galaxy Europe | Omicron and SARS-CoV-2 genome surveillance
